ESR2 and breast cancer: When ER-β expression was analyzed according to the novel BC classification (Figure 2a), we found that the receptor evenly distributes (P = 0.99) among the four molecular subtypes: indeed, ER-β stained positive in 54.7% of LA, 55.4% of LB, 55.3% of TN, and 56.3% of HS.